Singh Nupur
University of Tennessee Health Science Center, Memphis, TN, USA.
J Patient Exp. 2024 Nov 3;11:23743735241297488. doi: 10.1177/23743735241297488. eCollection 2024.
Isotretinoin is a form of Vitamin A used in treatment of severe, refractory acne vulgaris with treatment duration ranging anywhere from 3 to 12 months. The side effects of isotretinoin require monthly dermatologist visits and utilize a risk-management program called iPLEDGE REMS run by the Federal Drug Administration (FDA), which verifies that patients are not pregnant while starting or while taking isotretinoin. The physical and mental side effects experienced on isotretinoin are unique to each patient and can be severely debilitating. My own experience taking isotretinoin for 8 months was filled with multiple unexpected side effects that affected both my physical and mental health. As a result, I strongly believe dermatologists should help patients in analyzing the risk versus benefit profile of isotretinoin, present all other options, and ultimately emphasize patient-provider shared-decision making. Furthermore, at monthly visits dermatologists should be required to implement open dialogue regarding side effects to avoid patient feelings of fear and shame. Additionally, the iPLEDGE REMS system should consider creating a systematic documentation of symptoms to help normalize experiences and guide treatment plans.
异维A酸是维生素A的一种形式,用于治疗重度难治性寻常痤疮,治疗持续时间从3个月到12个月不等。异维A酸的副作用要求患者每月看一次皮肤科医生,并使用由美国食品药品监督管理局(FDA)管理的名为iPLEDGE REMS的风险管理计划,该计划可确保患者在开始服用或正在服用异维A酸时未怀孕。服用异维A酸时出现的身体和精神副作用因人而异,可能会严重影响身心健康。我自己服用异维A酸8个月的经历充满了多种意想不到的副作用,这些副作用同时影响了我的身心健康。因此,我坚信皮肤科医生应该帮助患者分析异维A酸的风险与益处,提供所有其他选择,并最终强调医患共同决策。此外,在每月的复诊中,应要求皮肤科医生就副作用展开公开对话,以避免患者产生恐惧和羞耻感。此外,iPLEDGE REMS系统应考虑创建症状的系统记录,以帮助使患者的经历正常化并指导治疗方案。